Eiger BioPharmaceuticals Inc

NASDAQ:EIGR   3:59:52 PM EDT
8.22
+0.19 (+2.37%)
Other Pre-Announcement

Eiger BioPharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results

Published: 03/09/2021 22:37 GMT
Eiger BioPharmaceuticals Inc (EIGR) - Eiger Biopharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update.
Eiger Biopharmaceuticals Inc Qtrly Loss per Share $0.58.
Eiger Biopharmaceuticals Inc - Pro-forma Cash, Cash Equivalents and Investments of $176.2 Million Expected to Fund Planned Operations Through Q4 2023.